USPTO serial 78190886
CARBOSPIN
Reviewed by CopyMark Law Group
Reg. 2864844Status 710
- Filing date
- Status date
- Registration date
- Jul 20, 2004
- Examiner
- KING, LINDA M
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with CARBOSPIN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
BUCKINGHAMSHIRE, GB
Little Chalfont, GB
Little Chalfont, GB
Little Chalfont, GB
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Catherine Mennenga
CATHERINE MENNENGA GENERAL ELECTRIC COMPANY3135 EASTON TPKEFAIRFIELD, DC 06828-0001UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Diagnostic chemicals, biochemicals and reagents for scientific, research or industrial use; chemical diagnostic preparations for scientific use, namely, chemical preparations for cell separation and culture, nucleic acid purification, nucleotides, fluorescent nucleotides, oligonucleotides, peptides, proteins, amino acids, organic molecules, and markers for DNA/RNA synthesis; diagnostic reagents for scientific or research use, namely, reagents for luminescence, reagents for gene expression quantification, reagents for use with polymerize chain reaction process, reagents for use with the rolling circle amplification process, reagents for cDNA cloning and vectors, modifying and restriction enzymes, reagents for labeling, sequencing and fragment analysis of nucleic acids, proteins and custom synthesis, reagents for recombinant protein expression purification, reagents for electrophoresis, bioinformatics, spectrophotometry and fluorometry, reagents for scintillating proximity assays, and reagents for high resolution laser fluorescence confocal microscopy; chromatography chemicals; diagnostic radiochemicals for scientific or research use; high through put screening assays for use in the manufacture of pharmaceuticals; and gaseous diagnostic chemicals for scientific or research use | SECTION 8 - CANCELLED | — |
| 005 | Diagnostic preparations and reagents for medical laboratory use; contrast media for in-vivo imaging; contrasting agents for ultrasound diagnostic imaging; contrast media for use with magnetic resonance imaging; radiopharmaceutical preparations for diagnostic purposes; diagnostic radioactive pharmaceutical preparations and non-radioactive reagents for medical laboratory use; and gas and gas mixtures for in vivo diagnostic imaging | SECTION 8 - CANCELLED | — |
| 009 | Scientific apparatus and instruments used for the purpose of measuring, monitoring and surveying, namely, optical imaging systems which detect and quantiate light from a range of radiometric, luminescence and fluorescence assays; computer hardware and computer printers; computer software and computer programs in the field of life science, biotechnology and medical information; radiology apparatus and instruments for the reading and interpretation of autoradiographs and films including automated film readers and scanners; apparatus for electrophoresis, namely, modular, flatbed systems pre-qualify solutions for PCR sequencing, DNA mapping, and clone analysis in the field of biotechnology; gas chromatography apparatus, namely, chromatography columns and pumps; apparatus for bioinformatics systems, namely, computer software for data management in the fields of sequencing, microarrays, proteomics and medical information; apparatus for scintillation, namely, microplates for scintillating assays; apparatus for manufacturing oligonucleotides, namely, DNA/RNA synthesizer systems for the synthesis of oligonucleotides; apparatus for microarrays, namely, cellular screening systems for high-throughput and high-content sub-cellular imaging and analysis; glass microarray slides for scientific purposes; laser based optical scanners for digital imaging; laboratory glassware; laboratory equipment and supplies, namely, vials and microvials, and microtitre plates | SECTION 8 - CANCELLED | — |
| 010 | Electromagnetic medical diagnostic imaging apparatus for radioactive and luminescent emissions; surgical, medical, dental and veterinary apparatus and instruments used for the purpose of measuring, monitoring and surveying, namely, MRI diagnostic apparatus; x-ray apparatus for medical use; computerized tomography scanners and ultrasound diagnostic apparatus; radiological apparatus for diagnostic and medical purposes, namely, cylindrical generators containing the radionuclide molybdenum-99 which produces radionuclide technetium-99m; medical test kits for diagnostic purposes, including test tubes, test plates and indicator charts for evaluating test results; cannulas; medical syringes; infusion pumps for intravenous administration of fluids; needles for medical use; implantable radiation therapy devices consisting of encapsulated radioisotope brachytherapy sources containing iodine-125 seeds for in vivo use; and a radiation delivery system consisting primarily of radioactive seeds and a bio-absorbable carrier assembly | SECTION 8 - CANCELLED | — |
| 041 | Educational services, namely, conducting seminars in the field of medical imaging and diagnostics; conducting seminars, conferences, symposiums and workshops in the field of pharmaceuticals for medical practitioners and employees of pharmaceutical companies; conducting seminars in the field of life science and biotechnology for scientists and researchers; and training services in the fields of medical imaging and diagnostics, pharmaceuticals for medical practitioners and employees of pharmaceutical companies, and life science and biotechnology for scientists and researchers | SECTION 8 - CANCELLED | — |
| 042 | Scientific research; research and development for new products for others; technical consultation and research in the field of life science and biotechnology; technical consultation and research in the field of discovery and evaluation of drugs and compounds having diagnostic properties; technical support services, namely, troubleshooting of computer hardware and software problems; technical consultation and research in the field of methods for diagnosis using laser based optical systems; technical consultation and research in the field of high through put screening assays for drug development services; customer synthesis services, namely, radioactive and non-radioactive labeling of a compound; chemical and biotechnological analysis services | SECTION 8 - CANCELLED | — |
| 044 | Providing medical information; and medical imaging services; diagnostic services in the field of MRI, x-ray, computerized tomography scanners, ultrasound, positron emission tomography and hyperpolarization; technical consultation and research in the field of pharmaceuticals; technical consultation and research in the field of medical and diagnostic imaging; and technical consultation and research in the field of diagnostic, prophylactic and/or therapeutic properties for medical research | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by GE HEALTHCARE LIMITED
- Other trademarks owned by AMERSHAM PLC
- Other trademarks owned by AMERSHAM PLC
- Other trademarks owned by AMERSHAM PLC
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named CARBOSPIN
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 25, 2011 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Jan 12, 2005 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 12, 2005 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 20, 2004 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 27, 2004 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 7, 2004 | NPUB | NOTICE OF PUBLICATION | — |
| Feb 12, 2004 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 23, 2004 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 23, 2004 | PAPER RECEIVED | — | |
| Jul 23, 2003 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 2, 2003 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 30, 2003 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 9, 2003 | PAPER RECEIVED | — |